Molar Incisor Hypomineralization and Hypomineralized Second Primary Molars
NCT ID: NCT05809791
Last Updated: 2025-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
97 participants
OBSERVATIONAL
2021-03-02
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of a Glass Ionomer Sealant in Molar Incisor Hypomineralization
NCT05806398
Molar Incisor Hypomineralisation and Dental Anomalies
NCT05812690
Prevalence of Hypomineralized Second Primary Molars and Its Association with Molar-Incisor Hypomineralization.
NCT06727539
Knowledge of Egyptian Dental Practitioners Regarding Molar-Incisor Hypomineralization
NCT04231019
Prevalence, Etiology and Effects on Oral Health and Life Quality of Molar Incisor Hypomineralization
NCT05779332
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signature of the informed consent to the study by patients' parents or by their legal guardians
Exclusion Criteria
* Patients not sufficiently cooperative;
* Children with orthodontic devices hiding the teeth to consider
6 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Burlo Garofolo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Milena Cadenaro, MD
Role: STUDY_DIRECTOR
IRCCS materno infantile Burlo Garofolo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Burlo Garofolo
Trieste, Italy, Italy
Maggiore Hospital
Trieste, Trieste, Italy
IRCCS Burlo Garofolo
Trieste, , Italy
Servicio de Odontología de la Universidad de Zaragoza
Huesca, Huesca, Spain
Faculty of Dentistry of the Yeditepe University
Istanbul, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC 11/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.